Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions Thursday July 11

ThPeB7388 Time-to-clinical-stability in HIV-patients with
community-acquired pneumonia (CAP)
P Viale L Scudeller, B Cadeo, N Petrosillo,
L Pagani, L Signorini, E Girardi, G Carosi (Italy)
ThPeB7389 Compliance to treatment appointments for
quality of care in an urban, H IV dental clinic
M C FAlves, R C FAlves, M E FAlves
(United States)
ThPeB739o Paracoccidioidomycosis with lesions of the oral
mucosa in AIDS patients, Sorocaba, SP, 2001
N T L Litterio, G S Silva ir, j R M Marins (Brazil)
ThPeB7391 Profile of the dental needs of an urban HIV/AIDS
population
M E FAlves, M C FAlves, R C FAlves
(United States)
ThPeB7392 Cardiovascular risk factors in HIV-infected
patients receiving protease inhibitors
J Whetham, A M Smith, I G Williiams
(United Kingdom)
ThPeB7393 Multicentric electronic-based surveillance of
treatment-limiting adverse events under HAART
in the clinical setting. The Italian MASTER clinical
data-base
G Carosi, F Castelli, L Tomasoni, A Patroni,
C Tinelli, G P Cadeo, D Bertelli, A M Orani (Italy)
ThPeB7394 Surveillance for clinical manifestations of
HIV/AIDS disease and opportunistic infections
(01) in Vietnam
H D Le', T T Cao', T T Trinh', CM Luu', G R West2,
M L Kamb' ('Vietnam; 2United States)
ThPeB7395 Increase of haemoglobin levels by antiretroviral
therapy is associated with a decrease in immune
activation
M Sarcletti G Quirchmair, D Fuchs, G Weiss,
R Zangerle (Austria)
ThPeB7396 Evaluation of pancrelipase (ultrase mt-2o) for the
symptomatic control of nelfinavir-associated
diarrhea
J Hellinger M Glesby, A Stein, A Talal, S A Tuscher,
T Greenough, M Becker, A Chu, A B Morris,
CJ Cohen (United States)
ThPeB7397 Cervico-vaginal shedding of HIV-1 RNA in
presence of undetectable plasma HIV-1 RNA
during HAART: an evidence of female genital tract
H IV compartmentalization. Preliminary data of a
perspective study
N Abrescia P Martinelli, M Sansone, A Busto,
G Di Nicuolo, R Viglietti, M Figoni, M D'Abbraccio,
M De Marco, E Butrico, A Maddaloni, M Piccirillo
(Italy)
ThPeB7398 CD4 cell count (CD4) and HIV-1 RNA (VL) as timevarying predictors of AIDS morbidity and death
after HAART initiation
K Anastos, Y Barrdn, M Young, H Minkoff,
M Cohen, R Greenblatt, A Levine, S] Gange
(United States)
ThPeB7399 Predictive value of pap smear screening in HIVInfected and high risk HIV-uninfected women
I Anderson P Paramsothy, C Heilig, D jamieson,
K Shah, A Duerr (United States)
ThPeB74oo Prevalence of autoantibodies and
cryoglobulinemia in HIV-infected patients
F Bonnet, ] Pineau, A Feyler, I L Taupin,
M Bonarek, S de Witte, N Bernard, D Lacoste,
I Beylot, P Mor/at (France)
ThPeB74o1 Pulmonary hypertension in HIV infected patients.
Report of seven cases

M Penaranda, A Salas, E Sala, M Riera, C Delibes,
M Villalonga, M Sanz, C Villalonga (Spain)

ThPeB74o2 HLA molecules in patients with AIDS who
developed cytomegalovirus retinitis
EA Donadi, J F Fiqueiredo, E Romao, N V Souza,
N H S Deghaide, M L V Rodrigues (Brazil)
ThPeC74o3 What can be learned from chronic, non-infected
injection drug users (IDUs): factors associated
with long-term HIV and HCV seronegativity.
I Bruneau S Brogly, F Lamothe, J Vincelette
(Canada)
ThPeC74o4 Longitudinal risk patterns after notification of HIV
seroconversion among injection drug users:
the ALIVE study 1998-2000
N Galai', M Safoeian2, DD Celentano2, D Vlahov2,
S A Strathdee2 (1srael; 2United States)
ThPeC74o5 Lack of HIV transmission through unprotected
orogenital sex among heterosexual HIVdiscordant couples
J Del Romero B Marincovich, J Castilla, S Garcia,
J Campo, V Hernando, D Rojas, C Rodriguez
(Spain)
ThPeC74o6 Factors related to HIV prevalence among female
partners of HIV-infected men
B Marincovich, Castilla, I del Romero, S Garcia,
C Rodriguez, A Barrasa, L Olmos (Spain)
ThPeC74o7 The feasibility of a randomized controlled trial of
male circumcision to reduce HIV incidence in
Kisumu, Kenya
R C Bailey', P L Okamo2, EM Oroko2, J 0 NdinyaAchola2, S Moses3 ('United States; 2Kenya;
3Canada)
ThPeC74o8 Intravaginal product use, HIV infection, and other
sexually transmitted infections in South Africa
L Myer, L Kuhn', L Denny2, M de Sousa2,
I Meulenberg2, T C Wright' ('United States;
2South Africa)
ThPeC74o9 HIV transmission in a cohort of serodiscordant
heterosexual couples
J Castilla B Marincovich, J del Romero, S Garcia,
M J Belza, C Rodriguez, L Olmos (Spain)
ThPeC741o Sexual risk behavior of HIV+ persons aware
versus unaware of their infection status: refining
the focus of HIV prevention efforts
G Marks, N Crepaz (United States)
ThPeC7411 HIV transmission between gay men through oral
sex: Seroconversion Study, Sydney
JRichters, Ellard, 0 Hendry, S Kippax (Australia)
ThPeC7412 Risk factors for recent HIV infection among MSM:
the Importance of Delayed Application of
Condoms. Results of the Polaris H IV
Seroconversion Study
L Calzavara, A Burchell, R S Remis, C Major,
P Corey, T Myers, P Millson, E Wallace, and the
Polaris Study Team (Canada)
ThPeC7413 Prevalence and incidence of HIV and sexually
transmitted infections (STI) among young women
in Thailand, Uganda and Zimbabwe participating
in the hormonal contraception and risk of HIV
acquisition cohort
R Salata', P Cornelisse, T Chipato2, F Mmiro3,
C Morrison', N Padian', S Rugpao4, D Celentano'
('United States; 2Zimbabwe; 3Uganda; 4Thailand)
ThPeC7414 Biological mechanisms of reduced HIV
acquisition in circumcised males: susceptibility of
human foreskin and cervical tissue to H IV-1
infection
R C Bailey B Patterson, I Siegel, A Landay
(United States)

Thursday

XIV International AIDS Conference BARCELONA - JULY 7-12

227